Interventional Cardiology · New York
Advanced cardiovascular
risk assessment. Built on decades
of clinical and research leadership.
Dr. Jonathan Marmur brings extensive clinical, research, and interventional experience to a highly individualized approach to cardiovascular risk assessment, prevention, and long-term management.

Jonathan D. Marmur, MD
Current Leadership
Chair of Cardiology
NYC Health + Hospitals / Elmhurst
Interventional Cardiology
Board-Certified
American Board of Internal
Medicine
Academic Medicine
25+ Years
Clinical, Research & Teaching
Professional Standards
ABIM
Interventional Cardiology Committee
Clinical Approach
Cardiovascular risk is rarely explained by a single test.
Dr. Marmur's approach integrates clinical history and risk factors with appropriate cardiovascular testing and advanced information to create a more complete understanding of individual cardiovascular risk.
01
Clinical History & Risk Factors
Comprehensive review of personal and family cardiovascular history, lifestyle factors, and established risk markers.
02
Advanced Biomarkers
Targeted laboratory analysis including high-sensitivity markers and novel cardiovascular indicators.
03
Cardiovascular Imaging
Coronary calcium scoring, echocardiography, vascular imaging, and advanced anatomic evaluation.
04
Genomics
Inherited risk assessment through genetic profiling relevant to cardiovascular predisposition.
05
Proteomics
Protein-level biomarker analysis to identify subclinical cardiovascular risk signals.
06
Integrated Clinical Interpretation
Synthesis of all data streams into a coherent, individualized clinical picture.
07
Individualized Management Strategy
A personalized, long-term plan for prevention, monitoring, and risk reduction.


01
Comprehensive Cardiovascular Assessment
→
02
Advanced Imaging & Vascular Evaluation
→
03
Genomic & Proteomic Risk Information
→
04
Long-Term Risk Management Strategy
→
Expert Witness
Independent cardiovascular expertise for complex medical matters.
Dr. Marmur's extensive clinical, interventional, research, and leadership experience provides a strong foundation for thorough and independent cardiovascular case review. His perspective spans decades of direct patient care, institutional leadership, and published investigation.
01
Medical Record Review
02
Cardiovascular Imaging Review
03
Standard-of-Care Analysis
04
Written Medical Opinion
05
Deposition & Trial Consultation


Book
Controlling the Agenda
A direct, practical guide to navigating difficult professional relationships. The book addresses the dynamics of difficult bosses, challenging coworkers, and complex workplace interactions — and offers strategic frameworks for managing communication, conflict, and professional outcomes with clarity and composure.
Also available as an audiobook narrated by Dr. Jonathan Marmur.
Research & Publications
Research that informs clinical judgment.
Dr. Marmur has contributed extensively to cardiovascular research, with publications spanning interventional cardiology, risk stratification, coronary physiology, and clinical investigation across leading peer-reviewed journals.
2016
Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Patients With and Without Acute Coronary Syndrome: A Systematic Review of Randomized Controlled Trials
Sharma A, Lavie CJ, Sharma SK, Garg A, Vallakati A, Mukherjee D, Marmur JD
Mayo Clinic Proceedings
2010
Relation Between Red Blood Cell Distribution Width (RDW) and All-Cause Mortality at Two Years in an Unselected Population Referred for Coronary Angiography
Cavusoglu E, Chopra V, Gupta A, Battala VR, Poludasu S, Eng C, Marmur JD
International Journal of Cardiology
2007
The F11 Receptor (F11R/JAM-A) in Atherothrombosis: Overexpression of F11R in Atherosclerotic Plaques
Babinska A, Azari BM, Salifu MO, Liu R, Jiang XC, Sobocka MB, Boo D, Al Khoury G, Deitch JS, Marmur JD, Ehrlich YH, Kornecki E
Thrombosis and Haemostasis
2006
Adiponectin Is an Independent Predictor of All-Cause Mortality, Cardiac Mortality, and Myocardial Infarction in Patients Presenting With Chest Pain
Cavusoglu E, Ruwende C, Chopra V, Yanamadala S, Eng C, Clark LT, Pinsky DJ, Marmur JD
European Heart Journal

Jonathan D. Marmur, MD
Clinical experience shaped by decades of cardiovascular leadership and research.
Dr. Jonathan D. Marmur is an interventional cardiologist and Chair of Cardiology at NYC Health + Hospitals / Elmhurst, where he has led clinical programs, trained the next generation of cardiologists, and contributed to cardiovascular research over more than 25 years.
His experience spans direct patient care, institutional leadership, catheterization laboratory direction, clinical investigation, and board-level service with the American Board of Internal Medicine's Interventional Cardiology Committee.
This depth of experience allows him to apply a multidimensional, individualized approach to cardiovascular risk assessment and prevention that goes beyond standard clinical protocols.
Cardiovascular Consultation
A more complete strategy for understanding cardiovascular risk.
Each assessment begins with a thorough, individualized review of your clinical history, risk factors, and goals — combining the full range of available evidence into a coherent, actionable strategy.
New York
© 2026 Jonathan D. Marmur, MD. All rights reserved.
Privacy
Accessibility
Terms
Interventional Cardiology · New York
Advanced cardiovascular risk assessment. Built on decades of clinical and research leadership.
Dr. Jonathan Marmur brings extensive clinical, research, and interventional experience to a highly individualized approach to cardiovascular risk assessment, prevention, and long-term management.

Jonathan D. Marmur, MD
Current Leadership
Chair of Cardiology
NYC Health + Hospitals / Elmhurst
Interventional Cardiology
Board-Certified
American Board of Internal Medicine
Experience
25+ Years
Clinical, Research & Teaching
Professional Leadership
ABIM
Interventional Cardiology Committee
Clinical Approach
Cardiovascular risk is rarely explained by a single test.
Dr. Marmur's approach integrates clinical history and risk factors with appropriate cardiovascular testing and advanced information to create a more complete understanding of individual cardiovascular risk.
01
Clinical History & Risk Factors
Comprehensive review of personal and family cardiovascular history, lifestyle factors, and established risk markers.
02
Advanced Biomarkers
Targeted laboratory analysis including high-sensitivity markers and novel cardiovascular indicators.
03
Cardiovascular Imaging
Coronary calcium scoring, echocardiography, vascular imaging, and advanced anatomic evaluation.
04
Genomics
Inherited risk assessment through genetic profiling relevant to cardiovascular predisposition.
05
Proteomics
Protein-level biomarker analysis to identify subclinical cardiovascular risk signals.
06
Integrated Clinical Interpretation
Synthesis of all data streams into a coherent, individualized clinical picture.
07
Individualized Management Strategy
A personalized, long-term plan for prevention, monitoring, and risk reduction.


01
Comprehensive Cardiovascular Assessment
→
02
Advanced Imaging & Vascular Evaluation
→
03
Genomic & Proteomic Risk Information
→
04
Long-Term Risk Management Strategy
→
Expert Witness
Independent cardiovascular expertise for complex medical matters.
Dr. Marmur's extensive clinical, interventional, research, and leadership experience provides a strong foundation for thorough and independent cardiovascular case review. His perspective spans decades of direct patient care, institutional leadership, and published investigation.
01
Medical Record Review
02
Cardiovascular Imaging Review
03
Standard-of-Care Analysis
04
Written Medical Opinion
05
Deposition & Trial Consultation

Book
Controlling the Agenda
A direct, practical guide to navigating difficult professional relationships. The book addresses the dynamics of difficult bosses, challenging coworkers, and complex workplace interactions — and offers strategic frameworks for managing communication, conflict, and professional outcomes with clarity and composure.
Also available as an audiobook narrated by Dr. Jonathan Marmur.
View on Amazon
Listen on Audible

Research & Publications
Research that informs clinical judgment.
Dr. Marmur has contributed extensively to cardiovascular research, with publications spanning interventional cardiology, risk stratification, coronary physiology, and clinical investigation across leading peer-reviewed journals.
2016
Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Patients With and Without Acute Coronary Syndrome: A Systematic Review of Randomized Controlled Trials
Sharma A, Lavie CJ, Sharma SK, Garg A, Vallakati A, Mukherjee D, Marmur JD
Mayo Clinic Proceedings
2010
Relation Between Red Blood Cell Distribution Width (RDW) and All-Cause Mortality at Two Years in an Unselected Population Referred for Coronary Angiography
Cavusoglu E, Chopra V, Gupta A, Battala VR, Poludasu S, Eng C, Marmur JD
International Journal of Cardiology
2007
The F11 Receptor (F11R/JAM-A) in Atherothrombosis: Overexpression of F11R in Atherosclerotic Plaques
Babinska A, Azari BM, Salifu MO, Liu R, Jiang XC, Sobocka MB, Boo D, Al Khoury G, Deitch JS, Marmur JD, Ehrlich YH, Kornecki E
Thrombosis and Haemostasis
2006
Adiponectin Is an Independent Predictor of All-Cause Mortality, Cardiac Mortality, and Myocardial Infarction in Patients Presenting With Chest Pain
Cavusoglu E, Ruwende C, Chopra V, Yanamadala S, Eng C, Clark LT, Pinsky DJ, Marmur JD
European Heart Journal

Jonathan D. Marmur, MD
Clinical experience shaped by decades of cardiovascular leadership and research.
Dr. Jonathan D. Marmur is an interventional cardiologist and Chair of Cardiology at NYC Health + Hospitals / Elmhurst, where he has led clinical programs, trained the next generation of cardiologists, and contributed to cardiovascular research over more than 25 years.
His experience spans direct patient care, institutional leadership, catheterization laboratory direction, clinical investigation, and board-level service with the American Board of Internal Medicine's Interventional Cardiology Committee.
This depth of experience allows him to apply a multidimensional, individualized approach to cardiovascular risk assessment and prevention that goes beyond standard clinical protocols.
Cardiovascular Consultation
A more complete strategy for understanding cardiovascular risk.
Each assessment begins with a thorough, individualized review of your clinical history, risk factors, and goals — combining the full range of available evidence into a coherent, actionable strategy.
New York
Author
Controlling the Agenda
Amazon ↗
Audible ↗
© 2026 Jonathan D. Marmur, MD. All rights reserved.
Privacy
Accessibility
Terms
Interventional Cardiology · New York
Advanced cardiovascular risk assessment. Built on decades of clinical and research leadership.
Dr. Jonathan Marmur brings extensive clinical, research, and interventional experience to a highly individualized approach to cardiovascular risk assessment, prevention, and long-term management.

Current Leadership
Chair of Cardiology
NYC Health + Hospitals / Elmhurst
Interventional Cardiology
Board-Certified
American Board of Internal Medicine
Experience
25+ Years
Clinical, Research &
Teaching
Professional Leadership
ABIM Member
Interventional Cardiology Committee
Clinical Approach
Cardiovascular risk is rarely explained by a single test.
Dr. Marmur's approach integrates clinical history and risk factors with appropriate cardiovascular testing and advanced information to create a more complete understanding of individual cardiovascular risk.
01
Clinical History & Risk Factors
Comprehensive review of personal and family cardiovascular history, lifestyle factors, and established risk markers.
02
Advanced Biomarkers
Targeted laboratory analysis including high-sensitivity markers and novel cardiovascular indicators.
03
Cardiovascular Imaging
Coronary calcium scoring, echocardiography, vascular imaging, and advanced anatomic evaluation.
04
Genomics
Inherited risk assessment through genetic profiling relevant to cardiovascular predisposition.
05
Proteomics
Protein-level biomarker analysis to identify subclinical cardiovascular risk signals.
06
Integrated Interpretation
Synthesis of all data streams into a coherent, individualized clinical picture.
07
Management Strategy
A personalized, long-term plan for prevention, monitoring, and risk reduction.




01
Comprehensive Cardiovascular Assessment
→
02
Advanced Imaging & Vascular Evaluation
→
03
Genomic & Proteomic Risk Information
→
04
Long-Term Risk Management Strategy
→
Expert Witness
Independent cardiovascular expertise for complex medical matters.
Dr. Marmur's extensive clinical, interventional, research, and leadership experience provides a strong foundation for thorough and independent cardiovascular case review. His perspective spans decades of direct patient care, institutional leadership, and published investigation.


01
Medical Record Review
02
Cardiovascular Imaging Review
03
Standard-of-Care Analysis
04
Written Medical Opinion
05
Deposition & Trial Consultation

Book
Controlling the Agenda
A direct, practical guide to navigating difficult professional relationships. The book addresses the dynamics of difficult bosses, challenging coworkers, and complex workplace interactions — and offers strategic frameworks for managing communication, conflict, and professional outcomes with clarity and composure.
Also available as an audiobook narrated by Dr. Jonathan Marmur.
Research & Publications
Research that informs clinical judgment.
Dr. Marmur has contributed extensively to cardiovascular research, with publications spanning interventional cardiology, risk stratification, coronary physiology, and clinical investigation across leading peer-reviewed journals.
2016
Publication
Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Patients With and Without Acute Coronary Syndrome: A Systematic Review of Randomized Controlled Trials
Sharma A, Lavie CJ, Sharma SK, Garg A, Vallakati A, Mukherjee D, Marmur JD
Mayo Clinic Proceedings
2010
Publication
Relation Between Red Blood Cell Distribution Width (RDW) and All-Cause Mortality at Two Years in an Unselected Population Referred for Coronary Angiography
Cavusoglu E, Chopra V, Gupta A, Battala VR, Poludasu S, Eng C, Marmur JD
International Journal of Cardiology
2007
Publication
The F11 Receptor (F11R/JAM-A) in Atherothrombosis: Overexpression of F11R in Atherosclerotic Plaques
Babinska A, Azari BM, Salifu MO, Liu R, Jiang XC, Sobocka MB, Boo D, Al Khoury G, Deitch JS, Marmur JD, Ehrlich YH, Kornecki E
Thrombosis and Haemostasis
2006
Publication
Adiponectin Is an Independent Predictor of All-Cause Mortality, Cardiac Mortality, and Myocardial Infarction in Patients Presenting With Chest Pain
Cavusoglu E, Ruwende C, Chopra V, Yanamadala S, Eng C, Clark LT, Pinsky DJ, Marmur JD
European Heart Journal


Jonathan D. Marmur, MD
Clinical experience shaped by decades of cardiovascular leadership and research.
Dr. Jonathan D. Marmur is an interventional cardiologist and Chair of Cardiology at NYC Health + Hospitals / Elmhurst, where he has led clinical programs, trained the next generation of cardiologists, and contributed to cardiovascular research over more than 25 years.
His experience spans direct patient care, institutional leadership, catheterization laboratory direction, clinical investigation, and board-level service with the American Board of Internal Medicine's Interventional Cardiology Committee.
This depth of experience allows him to apply a multidimensional, individualized approach to cardiovascular risk assessment and prevention that goes beyond standard clinical protocols.
Cardiovascular Consultation
A more complete strategy for understanding cardiovascular risk.
Each assessment begins with a thorough, individualized review of your clinical history, risk factors, and goals — combining the full range of available evidence into a coherent, actionable strategy.
Contact the Practice →
New York
Author
Controlling the Agenda
Amazon ↗
Audible ↗
© 2026 Jonathan D. Marmur, MD. All rights reserved.
Privacy
Accessibility
Terms